Identification of an immunogenic epitope and protective antibody against the furin cleavage site of SARS-CoV-2
Authors:
Open Access
- 9 December 2022
- journal article
- research article
- Published by Elsevier in EBioMedicine
- Vol. 87, 104401
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (AI158154)
- University of California, Los Angeles
- National Natural Science Foundation of China (81802870, 81925025, 82073181, 82102371, 91542201)
- Natural Science Foundation of Jiangsu Province (BE2022728, BK20211554)
- National Key Research and Development Program of China (2020YFC0841700)
- Chinese Academy of Medical Sciences Initiative for Innovative Medicine (2021-I2M-1-047, 2022-I2M-2-004)
This publication has 50 references indexed in Scilit:
- Transmission dynamics and evolutionary history of 2019‐nCoVJournal of Medical Virology, 2020
- A pneumonia outbreak associated with a new coronavirus of probable bat originNature, 2020
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor bindingThe Lancet, 2020
- Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmissionScience China Life Sciences, 2020
- The Immune Epitope Database and Analysis Resource in Epitope Discovery and Synthetic Vaccine DesignFrontiers in Immunology, 2017
- The SWISS-MODEL Repository—new features and functionalityNucleic Acids Research, 2016
- PyMod 2.0: improvements in protein sequence-structure analysis and homology modeling within PyMOLBioinformatics, 2016
- Automated comparative protein structure modeling with SWISS‐MODEL and Swiss‐PdbViewer: A historical perspectiveElectrophoresis, 2009
- Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirusNature, 2003
- MF59 Design and Evaluation of a Safe and Potent Adjuvant for Human Vaccines1995